Article
Gut Microbiome as a Potential Marker of Hematologic Recovery Following Induction Therapy in Acute Myeloid Leukemia Patients
27 Jan 2025
Abstract excerpt
BACKGROUND: The management of acute myeloid leukemia (AML) is hindered by treatment-related toxicities and complications, particularly cytopenia, which remains a leading cause of mortality. Given the pivotal role of the gut microbiota (GM) in hemopoiesis and immune regulation, we investigated its impact on hematologic recovery during AML induction therapy. METHODS: We profiled the GM of 27 newly diagnosed adult...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
